Lungs News and Research

RSS

Research findings unveil new avenues to monitor, treat lung cancer more effectively

A team of researchers from Singapore has discovered a class of small RNA molecules, known as oncomiRs, which are responsible for fuelling lung cancer.

12 Jul 2016

UNC experts advise against routine recommendation of e-cigarettes for smokers

The health benefits of quitting smoking are widely accepted, but researchers from the University of North Carolina at Chapel Hill have taken issue with the suggestion that doctors should routinely recommend e-cigarettes as an alternative to cigarettes for their patients who smoke.

12 Jul 2016

Major trial to test new surgical approach for patients with lung cancer

The University of Montreal Hospital Research Centre is launching a major international clinical trial to test a minimally invasive and safer surgical approach for patients with lung cancer: video-assisted thoracoscopic (VATS) lobectomy with ultrasonic pulmonary artery sealing.

11 Jul 2016

New diagnostic blood test may offer hope for transplant recipients through analysis of cfDNA

When cells die, whether through apoptosis or necrosis, the DNA and other molecules found in those cells don't just disappear. They wind up in the blood stream, where degraded bits and pieces can be extracted.

8 Jul 2016

Study underscores importance of evidence-based medical care in improving health of neonates

Born too soon, very premature infants are particularly vulnerable and need appropriate care.

8 Jul 2016

Study finds microRNA let-7 plays key role in restricting neuroblastoma

Great strides have been made in treating neuroblastoma, the most common cancer in infants and toddlers. However, advanced cases are often fatal, and children who survive often face life-long physical and intellectual challenges related to their treatment.

8 Jul 2016

UCLA researchers develop new combination therapy to activate immune response against glioblastoma

UCLA researchers have developed a new breakthrough combination treatment that utilizes a vaccine to activate an immune response against advanced brain tumors.

8 Jul 2016

Scientists identify how tumor cells exploit function of mitochondria to support cancer proliferation

As the powerhouse of the cells, mitochondria are critical for every organism because of their role in producing energy while also controlling survival, but how they function in cancer is still not completely known.

8 Jul 2016

Imaging technique could help doctors identify patients who may benefit breast cancer treatment

Cancer Research UK scientists have used imaging techniques as a new way to identify patients who could benefit from certain breast cancer treatments, according to a study published in ONCOTARGET today, (Thursday).

8 Jul 2016

New microfluidic device allows scientists to use safe electric fields to treat cancer

Researchers at MIT's research center in Singapore have developed a new microfluidic device that tests the effects of electric fields on cancer cells.

7 Jul 2016

MultiTaction provides Meeting Room iWall solution for BLF’s parliamentary exhibition

MultiTaction, the world’s leading developer of interactive touch display systems is providing its MultiTaction Meeting Room iWall solution for a week-long parliamentary exhibition being held by the British Lung Foundation (BLF) at the Houses of Parliament from 4-8 July, to increase awareness about lung disease.

From Asthma + Lung UK 7 Jul 2016

New lung-targeted gene therapy shows promise in improving treatment for emphysema

Researchers have developed a new strategy using lung-targeted gene therapy that may lead to improved treatments for inherited diseases including emphysema.

6 Jul 2016

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year.

6 Jul 2016

Necitumumab drug shows minor added benefit in patients with metastatic NSCLC

The monoclonal antibody necitumumab has been approved since February 2016 for the treatment of patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) expressing non-small cell lung cancer (NSCLC) who have not received prior chemotherapy for this condition.

5 Jul 2016

British Lung Foundation launches exhibition at the houses of parliament

A week-long parliamentary exhibition is being held by the British Lung Foundation (BLF) in the Upper Waiting Hall at the houses of parliament from 4-8 July.

From Asthma + Lung UK 5 Jul 2016

FDA approves Absorb GT1 BVS to treat coronary artery disease

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease.

5 Jul 2016

Tiny viruses speed-up evolution of bacteria causing infections in cystic fibrosis patients

SCIENTISTS in the UK have found new evidence that tiny viruses called bacteriophages turbo-charge the evolution of bacteria that cause lung infections in Cystic Fibrosis patients.

5 Jul 2016

Bringing healthcare home: an interview with Dr Andrew Lin

The goal of CliniCloud is to bring healthcare home. For us, what that means is a patient-centered and patient-modeled healthcare system, where we focus on the fact that consumers want access to healthcare and to a doctor. We're building an ecosystem around the tools and the software to really enable that to happen as conveniently and as affordably as possible.

5 Jul 2016

Annual repeat CT scans can eliminate need for biopsy or surgery in NSNs

Annual low-dose computed-tomography (CT) screening can eliminate the need for biopsy or surgery in nonsolid lung nodules, according to a new study published online in the journal Radiology.

5 Jul 2016

First-line nivolumab promising in advanced NSCLC

Phase I results published in the Journal of Clinical Oncology suggest that nivolumab, either given alone or alongside platinum-based doublet chemotherapy, could have a role in the first-line treatment of advanced non-small-cell lung cancer.

5 Jul 2016

Lungs News and Research

Research findings unveil new avenues to monitor, treat lung cancer more effectively

UNC experts advise against routine recommendation of e-cigarettes for smokers

Major trial to test new surgical approach for patients with lung cancer

New diagnostic blood test may offer hope for transplant recipients through analysis of cfDNA

Study underscores importance of evidence-based medical care in improving health of neonates

Study finds microRNA let-7 plays key role in restricting neuroblastoma

UCLA researchers develop new combination therapy to activate immune response against glioblastoma

Scientists identify how tumor cells exploit function of mitochondria to support cancer proliferation

Imaging technique could help doctors identify patients who may benefit breast cancer treatment

New microfluidic device allows scientists to use safe electric fields to treat cancer

MultiTaction provides Meeting Room iWall solution for BLF’s parliamentary exhibition

New lung-targeted gene therapy shows promise in improving treatment for emphysema

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Necitumumab drug shows minor added benefit in patients with metastatic NSCLC

British Lung Foundation launches exhibition at the houses of parliament

FDA approves Absorb GT1 BVS to treat coronary artery disease

Tiny viruses speed-up evolution of bacteria causing infections in cystic fibrosis patients

Bringing healthcare home: an interview with Dr Andrew Lin

Annual repeat CT scans can eliminate need for biopsy or surgery in NSNs

First-line nivolumab promising in advanced NSCLC

The ultimate guide to lung research tools and protocols eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News